Eric Dobmeier - Jul 19, 2024 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ James Pennington, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Jul 19, 2024
Transactions value $
$0
Form type
3
Date filed
7/22/2024, 08:01 PM
Previous filing
Jun 27, 2024

No securities are beneficially owned.